James G. Bender, VP, Product Development & Mfg at ImmunoCellular Therapeutics, Ltd. (IMUC), sold 7,000 shares at $3.92 ($27K) on 2012-05-31, disclosed to the SEC on 2012-05-31.
Open-market sale of $27k IMUC by VP, Product Development & Mfg. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.92 | 6,800 | $27K | 97.1% |
| 2 | $3.94 | 200 | $788 | 2.9% |
| Total | $3.92 avg | 7,000 | $27K | 100% |
| Filing → |